Van Lanschot Kempen Logo
  • Home
  • Solutions
  • News & knowledge
  • About us
Oct 2014
Probiodrug logo
Sole global coordinator

Sole bookrunner
23 million
Initial public offering

Probiodrug

Probiodrug is a biopharmaceutical company dedicated to the research and development of novel therapeutic solutions to treat people with Alzheimer’s Disease.

  • Probiodrug floated on Euronext Amsterdam with an initial market capitalisation of €102m
  • Proceeds of the offering will be used to execute the phase 2a study of its lead product in Alzheimer’s patients
  • Efforts resulted in an order book mainly made up of long-term specialist investors, despite turbulent markets
     

Fully focused on your future

Private Banking

  • Offices
  • Business professionals
  • Executives
  • Doctors
  • Entrepreneurs
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions


Investment Management


Investment Banking



© Van Lanschot Kempen 2022
Security
Privacy & cookies
Disclaimer